PRIMMO 试验中接受 PD-1 阻断、放疗和免疫调节治疗的晚期宫颈癌与子宫内膜癌患者循环免疫细胞谱分析
Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation
纵向免疫变化,而非单纯的基线差异,可区分应答者与非应答者。
FRONTIER PAPERS
Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation
纵向免疫变化,而非单纯的基线差异,可区分应答者与非应答者。
A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillo
经改造以表达肿瘤反应性T细胞受体(TCR)的免疫细胞,作为单一疗法针对实体瘤的疗效有限。
Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts.
肿瘤微环境(TME)在多种肿瘤中发挥核心作用,尤其是通过营造免疫抑制性环境。
The Role of Mesothelin in Gynecological Tumors and Its Significance in Targeted Therapies-A Review.
间皮素(MSLN)是一种细胞表面糖蛋白,在正常组织中表达有限,但在包括妇科恶性肿瘤在内的实体瘤中频繁过表达。
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.
[本文是对DOI:10.3389/fimmu.2024.1485461文章的更正。]
The game changer in the cervical cancer therapeutic landscape: immunotherapy.
这些策略共同构成了一个动态的免疫肿瘤学领域,有望重新定义宫颈癌的治疗模式。
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.
我们的研究结果表明,抗间皮素 CAR-NK 细胞有望成为治疗宫颈癌以及其他间皮素阳性恶性肿瘤的潜在选择。
γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids.
我们建立了γδ T细胞与宫颈癌类器官的共培养系统,为优化针对宫颈癌的创新性患者特异性免疫疗法提供了一种新的体外模型。
The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytoto
尽管利用先天免疫激活来治疗多种癌症正受到越来越多的关注,但在人乳头瘤病毒(HPV)相关恶性肿瘤中却研究甚少。
MEMBER ACCOUNT
登录成功会直接打开下一页。